Novo CEO pressed by Senate to chop prices of being overweight, diabetes medicines CEO Lars Fruergaard Jørgensen instructed lawmakers the business would think about new talks with insurers with regards to the list charges of Wegovy and copyright if they pledge to help keep the medicines on their own formularies. https://labelthefigurewiththeitem59483.webdesign96.com/31172781/about-healthcare-news